索宝蛋白
(603231)
| 流通市值：18.01亿 | | | 总市值：32.45亿 |
| 流通股本：1.06亿 | | | 总股本：1.91亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,456,929,967.2 | 966,543,038.05 | 487,722,648.24 | 1,748,098,617.55 |
| 营业总成本 | 1,346,249,937.56 | 892,937,641.66 | 452,399,406.08 | 1,539,225,328.77 |
| 其他经营收益 | | | | |
| 营业利润 | 120,585,258.48 | 80,270,868.07 | 37,575,493.64 | 227,041,819.49 |
| 利润总额 | 117,772,427.78 | 80,081,683.05 | 37,562,502.66 | 223,595,718.48 |
| 净利润 | 98,278,325.21 | 67,111,886.82 | 31,497,538.27 | 189,716,351.28 |
| 每股收益 | | | | |
| 其他综合收益 | -21,992.36 | -24,530.74 | -8,507.93 | 11,335.77 |
| 综合收益总额 | 98,256,332.85 | 67,087,356.08 | 31,489,030.34 | 189,727,687.05 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,486,011,686.73 | 1,409,985,568.2 | 1,353,235,871.6 | 1,360,104,211.35 |
| 非流动资产: | | | | |
| 非流动资产合计 | 952,723,742.48 | 909,383,705.9 | 912,382,167.87 | 909,110,197.85 |
| 资产总计 | 2,438,735,429.21 | 2,319,369,274.1 | 2,265,618,039.47 | 2,269,214,409.2 |
| 流动负债: | | | | |
| 流动负债合计 | 349,684,993.16 | 260,046,144.55 | 217,499,020.76 | 241,493,927.19 |
| 非流动负债: | | | | |
| 非流动负债合计 | 52,825,815.42 | 54,267,485.69 | 21,323,969.09 | 21,012,325.38 |
| 负债合计 | 402,510,808.58 | 314,313,630.24 | 238,822,989.85 | 262,506,252.57 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,035,862,957.74 | 2,003,980,594.24 | 2,025,078,541.06 | 2,006,708,156.63 |
| 股东权益合计 | 2,036,224,620.63 | 2,005,055,643.86 | 2,026,795,049.62 | 2,006,708,156.63 |
| 负债和股东权益合计 | 2,438,735,429.21 | 2,319,369,274.1 | 2,265,618,039.47 | 2,269,214,409.2 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,633,752,301.07 | 1,073,179,318.82 | 524,820,413.74 | 2,029,025,213.81 |
| 经营活动现金流出小计 | 1,661,830,251.99 | 1,065,292,769.86 | 513,203,422.89 | 1,717,919,238.58 |
| 经营活动产生的现金流量净额 | -28,077,950.92 | 7,886,548.96 | 11,616,990.85 | 311,105,975.23 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 802,469,537.79 | 649,549,222.78 | 140,896,469.42 | 2,779,706,876.94 |
| 投资活动现金流出小计 | 763,831,238.43 | 584,951,538.65 | 105,529,660.79 | 3,113,500,067.4 |
| 投资活动产生的现金流量净额 | 38,638,299.36 | 64,597,684.13 | 35,366,808.63 | -333,793,190.46 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 239,648,000 | 85,874,000 | 45,774,000 | 47,548,000 |
| 筹资活动现金流出小计 | 140,504,777.23 | 115,599,419.17 | 57,789,632.37 | 106,573,882.56 |
| 筹资活动产生的现金流量净额 | 99,143,222.77 | -29,725,419.17 | -12,015,632.37 | -59,025,882.56 |
| 汇率变动对现金及现金等价物的影响 | -10,445,423.82 | -8,346,883.12 | -4,214,952.37 | 333,651.31 |
| 现金及现金等价物净增加额 | 99,258,147.39 | 34,411,930.8 | 30,753,214.74 | -81,379,446.48 |
| 期末现金及现金等价物余额 | 337,900,048.32 | 273,053,831.73 | 269,395,115.67 | 238,641,900.93 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 34,411,930.8 | - | -81,379,446.48 |